The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126305994 12630599 4 F 20160716 20160909 20160808 20160916 EXP US-PFIZER INC-2016369140 PFIZER 16.00 YR M Y 59.00000 KG 20160916 OT US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126305994 12630599 1 SS MYLOTARG GEMTUZUMAB OZOGAMICIN 1 Intravenous (not otherwise specified) 3 MG/M2, DAY 1 AND DAY 5 Y 0 3 MG/M**2 POWDER FOR SOLUTION FOR INJECTION
126305994 12630599 2 PS DAPTOMYCIN. DAPTOMYCIN 1 Intravenous (not otherwise specified) 463 MG, DAILY FOR 7 DOSES 202857 463 MG POWDER FOR INJECTION QD
126305994 12630599 3 SS DIFLUCAN FLUCONAZOLE 1 Oral 300 MG (1 TABLET), 2X/DAY FOR 21 DOSES 19949 300 MG FILM-COATED TABLET BID
126305994 12630599 4 SS CORTEF HYDROCORTISONE 1 Oral 2.5 MG, 2X/DAY 25 MG Y 8697 2.5 MG TABLET BID
126305994 12630599 5 SS SOLU-MEDROL METHYLPREDNISOLONE SODIUM SUCCINATE 1 Intravenous (not otherwise specified) 40 MG, ONCE PRIOR TO INFUSION Y 0 40 MG
126305994 12630599 6 C ATIVAN LORAZEPAM 1 UNK 0 TABLET
126305994 12630599 7 C MAGNESIUM OXIDE. MAGNESIUM OXIDE 1 UNK 0 TABLET
126305994 12630599 8 C ZOFRAN ONDANSETRON HYDROCHLORIDE 1 UNK 0
126305994 12630599 9 C ZOLINZA VORINOSTAT 1 Oral 400 MG, DAILY 0 400 MG CAPSULE
126305994 12630599 10 C LEVAQUIN LEVOFLOXACIN 1 Oral 500 MG, DAILY 0 500 MG TABLET
126305994 12630599 11 C ZYLOPRIM ALLOPURINOL 1 UNK 0 TABLET

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126305994 12630599 1 Acute myeloid leukaemia recurrent
126305994 12630599 2 Antibiotic therapy
126305994 12630599 3 Antifungal treatment
126305994 12630599 4 Adrenal insufficiency
126305994 12630599 5 Steroid therapy
126305994 12630599 6 Anxiety
126305994 12630599 7 Blood magnesium decreased
126305994 12630599 8 Nausea
126305994 12630599 9 Neoplasm malignant
126305994 12630599 10 Infection
126305994 12630599 11 Blood uric acid increased

Outcome of event

Event ID CASEID OUTC COD
126305994 12630599 OT
126305994 12630599 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
126305994 12630599 Abdominal pain
126305994 12630599 Blood bilirubin increased
126305994 12630599 Hypokalaemia
126305994 12630599 Hyponatraemia
126305994 12630599 Lymphocyte count decreased
126305994 12630599 Neutrophil count decreased
126305994 12630599 Platelet count decreased
126305994 12630599 Vomiting
126305994 12630599 White blood cell count decreased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
126305994 12630599 1 20160715 20160719 0
126305994 12630599 2 20160725 0
126305994 12630599 3 20160725 0
126305994 12630599 4 20160725 20160730 0
126305994 12630599 5 20160724 20160724 0
126305994 12630599 6 20160718 0
126305994 12630599 7 20160729 0
126305994 12630599 8 20151209 0
126305994 12630599 9 20160716 20160725 0
126305994 12630599 10 20160725 20160808 0
126305994 12630599 11 20160722 20160729 0